+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors



Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors



Plos One 9(12): E115715



Recently, we could show that angiotensin II, the reactive peptide of the blood pressure-regulating renin-angiotensin-aldosterone-system, causes the formation of reactive oxygen species and DNA damage in kidneys and hearts of hypertensive mice. To further investigate on the one hand the mechanism of DNA damage caused by angiotensin II, and on the other hand possible intervention strategies against end-organ damage, the effects of substances interfering with the renin-angiotensin-aldosterone-system on angiotensin II-induced genomic damage were studied. In C57BL/6-mice, hypertension was induced by infusion of 600 ng/kg • min angiotensin II. The animals were additionally treated with the angiotensin II type 1 receptor blocker candesartan, the mineralocorticoid receptor blocker eplerenone and the antioxidant tempol. DNA damage and the activation of transcription factors were studied by immunohistochemistry and protein expression analysis. Administration of angiotensin II led to a significant increase of blood pressure, decreased only by candesartan. In kidneys and hearts of angiotensin II-treated animals, significant oxidative stress could be detected (1.5-fold over control). The redox-sensitive transcription factors Nrf2 and NF-κB were activated in the kidney by angiotensin II-treatment (4- and 3-fold over control, respectively) and reduced by all interventions. In kidneys and hearts an increase of DNA damage (3- and 2-fold over control, respectively) and of DNA repair (3-fold over control) was found. These effects were ameliorated by all interventions in both organs. Consistently, candesartan and tempol were more effective than eplerenone. Angiotensin II-induced DNA damage is caused by angiotensin II type 1 receptor-mediated formation of oxidative stress in vivo. The angiotensin II-mediated physiological increase of aldosterone adds to the DNA-damaging effects. Blocking angiotensin II and mineralocorticoid receptors therefore has beneficial effects on end-organ damage independent of blood pressure normalization.

(PDF emailed within 1 workday: $29.90)

Accession: 058488407

Download citation: RISBibTeXText

PMID: 25551569


Related references

Heart and kidneys as target organs for angiotensin II-induced oxidative stress in hypertensive rats. Nephrology Dialysis Transplantation 17(Abstracts Supplement 1): 77, 2002

The effects of aldosterone blocking agent canrenoate potassium and angiotensin i ii converting enzyme inhibitor captopril upon activated renin angiotensin aldosterone system after open heart surgery. Medical Journal of Kobe University 44(1): 33-48, 1983

Tissue angiotensin II concentration in the heart and kidneys in transgenic tsukub hypertensive mice. Blood Pressure 7(1): 61-63, 1998

Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 109(18): 2213-2220, 2004

Renal damage after myocardial infarction is prevented by renin-angiotensin-aldosterone-system intervention. Journal of the American Society of Nephrology 17(11): 3059-3066, 2006

DNA damage and augmented oxidative stress in bone marrow mononuclear cells from Angiotensin-dependent hypertensive mice. International Journal of Hypertension 2013: 305202, 2013

Cardiac and renal damage in aldosterone-infused mice is prevented by magnesium supplementation. 2007

Drugs with blocking effects on the renin-angiotensin-aldosterone system do not improve endothelial dysfunction long-term in hypertensive patients. Journal of International Medical Research 37(4): 996-1002, 2009

Multiple renin-angiotensin-aldosterone-blocking agents in heart failure: how much is too much?. Current Heart Failure Reports 6(2): 112-116, 2009

Blockade of the renin-angiotensin-aldosterone system: effects on hypertensive target organ damage. Cardiovascular and Hematological Agents in Medicinal Chemistry 4(3): 219-228, 2006

Unraveling the mechanism of renin-angiotensin- aldosterone system activation and target organ damage in hypertensive blacks. Hypertension 59(1): 10-11, 2012

Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system. Medical Clinics of North America 88(1): 83-97, 2004

Angiotensin II-induced hypertension dose-dependently leads to oxidative stress and DNA damage in mouse kidneys and hearts. Journal of Hypertension 31(2): 333-344, 2013

Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration. Journal of Laboratory and Clinical Medicine 122(4): 404-411, 1993